Yili Chuanning Biotechnology Co.,Ltd.

SZSE:301301 Voorraadrapport

Marktkapitalisatie: CN¥32.2b

Yili Chuanning BiotechnologyLtd Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Xuheng Deng

Algemeen directeur

CN¥1.4m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Geen updates

Recent updates

These 4 Measures Indicate That Yili Chuanning BiotechnologyLtd (SZSE:301301) Is Using Debt Safely

Oct 11
These 4 Measures Indicate That Yili Chuanning BiotechnologyLtd (SZSE:301301) Is Using Debt Safely

If EPS Growth Is Important To You, Yili Chuanning BiotechnologyLtd (SZSE:301301) Presents An Opportunity

Jul 23
If EPS Growth Is Important To You, Yili Chuanning BiotechnologyLtd (SZSE:301301) Presents An Opportunity

We Think Yili Chuanning BiotechnologyLtd (SZSE:301301) Can Manage Its Debt With Ease

May 31
We Think Yili Chuanning BiotechnologyLtd (SZSE:301301) Can Manage Its Debt With Ease

Yili Chuanning BiotechnologyLtd (SZSE:301301) Could Easily Take On More Debt

Feb 26
Yili Chuanning BiotechnologyLtd (SZSE:301301) Could Easily Take On More Debt

CEO

Xuheng Deng (37 yo)

no data

Tenure

CN¥1,389,100

Compensatie

Mr. Xuheng Deng serves as GM & Director of Yili Chuanning Biotechnology Co.,Ltd.